Bibliographic Details
| Title: |
Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease. |
| Authors: |
Wada T; From the Research and Development Division, Senju Pharmaceutical Co., Ltd. (T.W., K.O.), Osaka, Japan., Omatsu K; From the Research and Development Division, Senju Pharmaceutical Co., Ltd. (T.W., K.O.), Osaka, Japan. Electronic address: k-omatsu@senju.co.jp., Pflugfelder SC; Baylor College of Medicine (S.C.P.), Houston, Texas, USA. |
| Source: |
American journal of ophthalmology [Am J Ophthalmol] 2026 Apr; Vol. 284, pp. 216-225. Date of Electronic Publication: 2026 Jan 17. |
| Publication Type: |
Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: |
Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
